Prism Medico & Pharmacy Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 701766,
    "name": "Prism Medico",
    "stock_name": "Prism Medico",
    "full_name": "Prism Medico & Pharmacy Ltd",
    "name_url": "stocks-analysis/prism-medico",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "26.99",
    "chg": 0.13,
    "chgp": "0.48%",
    "dir": 1,
    "prev_price": "26.86",
    "mcapval": "37.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512217,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE730E01016",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "17.85 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/prism-medico-701766-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Prism Medico & Pharmacy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prism-medico-pharmacy-ltd-is-rated-sell-4002740",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PrismMedicoPhar_mojoScore_4002740.png",
        "date": "2026-05-21 10:10:42",
        "description": "Prism Medico & Pharmacy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Prism Medico & Pharmacy Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/prism-medico-pharmacy-ltd-is-rated-sell-3981421",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PrismMedicoPhar_mojoScore_3981421.png",
        "date": "2026-05-08 10:10:44",
        "description": "Prism Medico &amp; Pharmacy Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Prism Medico & Pharmacy Ltd Valuation Shifts Signal Price Attractiveness Change",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-valuation-shifts-signal-price-attractiveness-change-3976713",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PrismMedicoPhar_valuationdot_3976713.png",
        "date": "2026-05-06 08:00:30",
        "description": "Prism Medico & Pharmacy Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a subtle but meaningful change in price attractiveness. This reclassification comes amid mixed financial metrics and a volatile market backdrop, prompting investors to reassess the stock’s appeal relative to its peers and historical benchmarks."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 34.49",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs3449-3967809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3967809.png",
        "date": "2026-04-29 09:43:32",
        "description": "Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a new 52-week high of Rs 34.49 on 29 Apr 2026, marking a remarkable 128.87% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades cautiously below key moving averages."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 34",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs34-3964632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3964632.png",
        "date": "2026-04-27 14:37:25",
        "description": "With a remarkable 131.29% gain over the past year, Prism Medico & Pharmacy Ltd surged to a fresh 52-week high of Rs 34 on 27 Apr 2026, outpacing the Sensex which declined by 2.48% during the same period. This milestone caps a four-day winning streak that has propelled the stock up by 9.47%, underscoring a strong momentum that is supported by a confluence of technical indicators."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 33.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs3365-3960367",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3960367.png",
        "date": "2026-04-24 09:42:50",
        "description": "Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a fresh 52-week high of Rs 33.65 on 24 Apr 2026, marking a remarkable 126.56% gain over the past year. This rally stands in stark contrast to the broader market’s decline, with the Sensex down 3.48% over the same period, underscoring the stock’s strong momentum and technical resilience."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 33.58",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs3358-3955528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3955528.png",
        "date": "2026-04-21 09:42:35",
        "description": "With a decisive break above its previous peak, Prism Medico & Pharmacy Ltd surged to a new 52-week high of Rs 33.58 on 21 Apr 2026, marking a remarkable 107.4% gain over the past year. This milestone comes amid a sustained rally supported by a confluence of bullish technical indicators and a broader market environment that has been steadily advancing."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 32.15",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-hits-new-52-week-high-at-rs3215-3953544",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PrismMedicoPhar_priceRelatedfactors_3953544.png",
        "date": "2026-04-20 09:44:11",
        "description": "Surging past its previous peak, Prism Medico & Pharmacy Ltd touched a fresh 52-week high of Rs 32.15 on 20 Apr 2026, marking a remarkable doubling in price from its low of Rs 12.49 over the past year. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators and steady market participation."
      },
      {
        "title": "Prism Medico & Pharmacy Ltd Gains 6.83%: Valuation Shift and 52-Week High Mark the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prism-medico-pharmacy-ltd-gains-683-valuation-shift-and-52-week-high-mark-the-week-3952501",
        "imagepath": "",
        "date": "2026-04-18 16:01:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> New 52-week high at Rs.31</p>\n                    <p><strong>15 Apr:</strong> Sharp 8.11% price surge on strong volume</p>\n                    <p><strong>16 Apr:</strong> Valuation shift to very expensive grade announced</p>\n                    <p><strong>17 Apr:</strong> Week closes at Rs.30.66, up 6.83% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.28.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.30.66</div><div class=\"stat-change positive\">+6..."
      }
    ],
    "total": 14,
    "sid": "701766",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/prism-medico-pharmacy-701766"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "28-May-2026",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 28th May 2026) which commenced at 03:00 P.M. and concluded at 05:00 P.M. have inter alia approved the following: ? The Board considered and approved the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "23-May-2026",
      "details": "Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of - the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Thursday the 28 day of May 2026 at 03:00 P.M. inter alia to: - 2026 Consider approve and take-on record the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "11-May-2026",
      "details": "Dear Sir / Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 11th May 2026) which commenced at 04:00 P.M. and concluded at 04:30 P.M. have inter alia approved the following: 1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates Chartered Accountants as internal auditors of the company for the financial year 2025-2026. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Prism Medico & Pharmacy Ltd is Rated Sell

2026-05-21 10:10:42

Prism Medico & Pharmacy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Prism Medico & Pharmacy Ltd is Rated Sell

2026-05-08 10:10:44

Prism Medico & Pharmacy Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Prism Medico & Pharmacy Ltd Valuation Shifts Signal Price Attractiveness Change

2026-05-06 08:00:30

Prism Medico & Pharmacy Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a subtle but meaningful change in price attractiveness. This reclassification comes amid mixed financial metrics and a volatile market backdrop, prompting investors to reassess the stock’s appeal relative to its peers and historical benchmarks.

Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 34.49

2026-04-29 09:43:32

Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a new 52-week high of Rs 34.49 on 29 Apr 2026, marking a remarkable 128.87% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades cautiously below key moving averages.

Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 34

2026-04-27 14:37:25

With a remarkable 131.29% gain over the past year, Prism Medico & Pharmacy Ltd surged to a fresh 52-week high of Rs 34 on 27 Apr 2026, outpacing the Sensex which declined by 2.48% during the same period. This milestone caps a four-day winning streak that has propelled the stock up by 9.47%, underscoring a strong momentum that is supported by a confluence of technical indicators.

Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 33.65

2026-04-24 09:42:50

Surging past its previous peaks, Prism Medico & Pharmacy Ltd touched a fresh 52-week high of Rs 33.65 on 24 Apr 2026, marking a remarkable 126.56% gain over the past year. This rally stands in stark contrast to the broader market’s decline, with the Sensex down 3.48% over the same period, underscoring the stock’s strong momentum and technical resilience.

Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 33.58

2026-04-21 09:42:35

With a decisive break above its previous peak, Prism Medico & Pharmacy Ltd surged to a new 52-week high of Rs 33.58 on 21 Apr 2026, marking a remarkable 107.4% gain over the past year. This milestone comes amid a sustained rally supported by a confluence of bullish technical indicators and a broader market environment that has been steadily advancing.

Broad-Based Technical Strength Lifts Prism Medico & Pharmacy Ltd to 52-Week High of Rs 32.15

2026-04-20 09:44:11

Surging past its previous peak, Prism Medico & Pharmacy Ltd touched a fresh 52-week high of Rs 32.15 on 20 Apr 2026, marking a remarkable doubling in price from its low of Rs 12.49 over the past year. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators and steady market participation.

Prism Medico & Pharmacy Ltd Gains 6.83%: Valuation Shift and 52-Week High Mark the Week

2026-04-18 16:01:21

Key Events This Week 13 Apr: New 52-week high at Rs.31 15 Apr: Sharp 8.11% price surge on strong volume 16 Apr: Valuation shift to very expensive grade announced 17 Apr: Week closes at Rs.30.66, up 6.83% for the week Week OpenRs.28.70 Week CloseRs.30.66+6...

View All News

Announcement

Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

28-May-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 28th May 2026) which commenced at 03:00 P.M. and concluded at 05:00 P.M. have inter alia approved the following: ? The Board considered and approved the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

23-May-2026 | Source : BSE

Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the meeting of - the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as the Company) is scheduled to be held at the registered office of the company i.e. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030 on Thursday the 28 day of May 2026 at 03:00 P.M. inter alia to: - 2026 Consider approve and take-on record the Audited Standalone Financial Results of the company along with the Auditors Report for the quarter and financial year ended 31st March as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company.

Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

11-May-2026 | Source : BSE

Dear Sir / Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 11th May 2026) which commenced at 04:00 P.M. and concluded at 04:30 P.M. have inter alia approved the following: 1. To appoint Mr. Harpreet Singh of M/s. S Harpreet and Associates Chartered Accountants as internal auditors of the company for the financial year 2025-2026. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."